id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1981-N-0013-0023,FDA,FDA-1981-N-0013,HFA-305 to the Procter & Gamble Company,Other,ACK-Acknowledgement Letter,2006-04-05T04:00:00Z,2006,4,,,2008-05-30T22:53:23Z,,0,0,09000064805aec8b
FDA-1981-N-0013-0024,FDA,FDA-1981-N-0013,HFA-305 to the Procter & Gamble Company,Other,ACK-Acknowledgement Letter,2006-04-05T04:00:00Z,2006,4,,,2008-05-30T22:52:26Z,,0,0,09000064805aec8c